People · Operator

Andrej Kiska

Named in public records as an officer, director or promoter · active 2019–2025 · Other Technology, Software / Tech

3
Companies
5
Filings
$32.3M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Surglogs, Inc.Other TechnologySeries A$15.4M$163.0M2019
Equilibre Technologies, Inc.Software / TechSeries A$11.7M$48.8M2022
Halusky, Inc.Other TechnologySeries A$5.2M$19.3M2025
Operator network

Andrej Kiska at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

John Bertrand · 6 companies · 1 sharedJohn BertrandPatrik Backman · 3 companies · 1 sharedPatrik BackmanJakub Jasak · 1 companies · 1 sharedJakub JasakJohn Hilinski · 1 companies · 1 sharedJohn HilinskiPeter Zajac · 1 companies · 1 sharedPeter ZajacDusan Kovacic · 2 companies · 1 sharedDusan KovacicImran Ghory · 1 companies · 1 sharedImran GhoryMartin Schmid · 1 companies · 1 sharedMartin SchmidMatej Moravcik · 1 companies · 1 sharedMatej MoravcikRudolf Kadlec · 1 companies · 1 sharedRudolf KadlecBrent Murri · 2 companies · 1 sharedBrent MurriFilip Stollar · 1 companies · 1 sharedFilip StollarSurglogs, Inc. · $15.4M raisedSurglogs, Inc.Equilibre Technologies, Inc. · $11.7M raisedEquilibre Technologie…Halusky, Inc. · $5.2M raisedHalusky, Inc.Andrej KiskaAK
Andrej Kiska Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Andrej Kiska on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
John Bertrand16
Patrik Backman13
Dusan Kovacic12
Brent Murri12
Matej Moravcik11
Martin Schmid11
Jakub Jasak11
Peter Zajac11
John Hilinski11
Filip Stollar11
Imran Ghory11
Rudolf Kadlec11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.